Diclofenac market is anticipated to grow at a significant CAGR during the forecast period. The major factors that are expected to boost the market growth include increasing prevalence of autoimmune and respiratory conditions such as arthritis & dental pain, increasing demand for anti-inflammatory drugs, and development in R&D activities. Moreover, high demand for better and novel anti-inflammatory therapeutics with lesser side effects & better efficacy is another factor that is expected to provide lucrative opportunities for market growth during the forecast period.
Furthermore, the growing burden of the geriatric population and the rising adoption of diclofenac in treating sports-related injuries are further expected to fuel the global diclofenac market. However, the side effects of anti-inflammatory drugs and patent expiry issues of drugs are expected to hamper the market growth. Diclofenac is a non-steroidal anti-inflammatory drug (NSAID) that is mainly employed to treat mild-to-moderate pain & reduce pain, inflammation, swelling, and stiffness. This drug is applicable for inflammatory disorders such as arthritis, rheumatoid arthritis, dermatomyositis, osteoarthritis, dental pain, spondylarthritis, and gout attacks.
Disorders of the musculoskeletal system affect 70% of the population over the age of 50 years. At all stages of pain treatment, diclofenac sodium can be used in combination with co-diclofenac sodium including sedatives, antidepressants, and anti-epileptics, which may contribute to a reduction in doses of diclofenac sodium drugs. Diclofenac sodium is the most commonly used painkiller, however, in recent years, it is experiencing a tragic fall in sales, owing to the associated risk of heart problems. Diclofenac Sodium is removed from over counter in several countries. Researchers suggest that diclofenac should be available only with a prescription, also should be accompanied by an appropriate front package warning about its potential risks.
To Request a Sample of our Report on Diclofenac Market: https://www.omrglobal.com/request-sample/diclofenac-market
Market Coverage
- The market number available for – 2021-2029
- Base year- 2021
- Forecast period- 2023-2029
Segment covered-
- By Indication
- By Route of Administration
Regions covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape: Pfizer Inc., Bayer AG, and Novartis International AG, among others.
Diclofenac Market Report by Segment
By Indication
- Osteoarthritis
- Ankylosing Spondylitis
- Dysmenorrhea
- Rheumatoid Arthritis
- Migraine
- Pain
By Route of Administration
- Oral
- Parenteral
A full Report of Diclofenac Market is Available @ https://www.omrglobal.com/industry-reports/diclofenac-market
Diclofenac Market Report by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East and Africa
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/diclofenac-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
